October 08, 2015 – Rostrum Medical Innovation Inc
Rostrum investors can receive a 30% refundable tax credit
Vancouver, B.C., Canada – October 8, 2015 – Rostrum Medical Innovation Inc., a Canadian medical device company, is pleased to announce it has received Eligible Business Corporation (EBC) Status under section 28 of the Small Business Venture Capital Act.
The EBC status is an investment option to promote capital investments in early stage companies and was established under the Equity Capital Program by the Ministry of International Trade in the Province of British Columbia, Canada. This program is ideal for investors who want to support the growth of small business throughout B.C. and offers companies the same benefits as a Venture Capital Corporation (VCC). Venture capital programs encourage investors to make investments in British Columbia small businesses that will enhance and diversify the provincial economy. Investors are entitled to a 30 percent refundable tax credit on the value of their investment. For more information about this program, visitwww.mit.gov.bc.ca
“We are very pleased that Rostrum Medical has qualified for the EBC status,” said Mr. Awni Ayoubi, President of Rostrum Medical. “This allows B.C. investors who make eligible investments in Rostrum Medical to receive a 30% refundable tax credit”. Since its incorporation in 2009, Rostrum Medical has raised CAD $3.6 million through internal private financing, and additional equal amounts through grants, investment tax credits. Rostrum Medical is currently seeking additional funds to complete and expand global clinical studies and begin global commercialization for the company’s novel device, the VQm®.
Rostrum Medical is poised to become a global medical device company with a focus on innovative respiratory monitoring.
About Rostrum Medical®
Rostrum is a privately held corporation, registered under the laws of Canada. Rostrum commenced its operation in January 2009, with a focus on providing medical practitioners with new and useful solutions to everyday challenges experienced in the healthcare industry. A team of leading clinicians, combined with our engineering and business expertise, allows Rostrum Medical® to deliver leading edge solutions to problematic uncertainties in modern day practice.
Rostrum’s VQm® System is a new device for direct measurement of thermal and hygrometric changes in patients breathing gases during the respiratory cycle to assess ventilation/perfusion efficiencies (V/Q matching) in intubated and ventilated patients.
Press Contact Information:
Rostrum Medical Innovations Inc.